ArisGlobal recognized by Frost & Sullivan for enabling life sciences companies to accelerate R&D with its LifeSphere platform
MIAMI – August 10, 2021 – ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 300 life sciences companies, today announced it has been awarded the 2021 North America Customer Value Leadership award by Frost & Sullivan. ArisGlobal is recognized for transforming the way life sciences companies manage clinical development and drug safety with its LifeSphere platform, an intelligent cloud software suite, that enables life sciences companies to bring safer products to market faster.
“The Frost & Sullivan award validates ArisGlobal’s innovative approach as we continue to deliver superior technology to the life science industry and only enhances our efforts in delivering high-quality, cloud software solutions to our customers,” said Sankesh Abbhi, president and CEO of ArisGlobal. “Our goal is to be the leading technology platform for all life science companies as they continue to transform global health.”
The North America Customer Value Leadership award is given to the organization that demonstrates excellence in implementing strategies that proactively create value for its customers, focusing on improving the return on the investment that customers make in its services or products.
“ArisGlobal was awarded the 2021 North America Customer Value Leadership for their unique focus to elevate the life science industry with the all-encompassing LifeSphere platform,” said Amol Jadhav, senior industry analyst for Frost & Sullivan. “A data-first solution, LifeSphere is the golden source to help R&D teams ranging from clinical to medical affairs and continuously makes a positive impact in the life sciences industry.”
ArisGlobal’s LifeSphere platform is the only unified platform in the market spanning cloud applications and includes the following:
- Clinical (LifeSphere CTMS and LifeSphere EDC) for clinical operations and data management that accelerates studies, ensures transparency and streamlines collaboration across an organization.
- Regulatory (LifeSphere RIMS and LifeSphere Publishing) delivers end-to-end regulatory information management that expedites speed to market, enhances data quality and streamlines collaboration across teams.
- Safety (LifeSphere MultiVigilance, LifeSphere Intake & Triage and LifeSphere Signal & Risk Management) an end-to-end platform that helps hundreds of pharmacovigilance teams around the world save time and effort, ensure future-proof compliance and unlock deep insights from safety data.
- Medical affairs (LifeSphere Medical Information and LifeSphere Reporter) helps life sciences organizations deliver timely information, stay compliant and streamline collaboration between global stakeholders.
LifeSphere supports hundreds of global life sciences companies to accelerate development, maintain compliance and streamline collaboration between cross-functional teams.
The award follows ArisGlobal’s recent announcement of Xihua Scientific selecting LifeSphere MultiVigilance to advance pharmacovigilance services. To learn more about ArisGlobal and its LifeSphere platform please visit, www.arisglobal.com.
Download ArisGlobal’s 2024 Industry Report 
